Florian Voss - Boehringer Ingelheim | 人才画像

基本信息

Career Trajectory

Bio

Florian Voss studied mathematics at Ulm University in Ulm, Germany, and at the University of Cantabria in Santander, Spain. He received the Dipl.-Math. oec. (M.Sc.) degree in economy mathematics from Ulm University in 2005. Afterwards he joined the Institute of Stochastics at Ulm University, where he is now working toward the PhD degree. His research interests include spatial stochastic models, in particular random tessellations and point processes, and their applications to telecommunication network modeling.

Research Interests

Papers共 109 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Nerandomilast in Patients with Progressive Pulmonary Fibrosis

Toby M Maher,Shervin Assassi,Arata Azuma,Vincent Cottin, Anna-Maria Hoffmann-Vold,Michael Kreuter,Justin M Oldham,Luca Richeldi,Claudia Valenzuela, Marlies S Wijsenbeek,Emmanuelle Clerisme-Beaty,Carl Coeck, Hui Gu,Ivana Ritter, Arno Schlosser,Susanne Stowasser,Florian Voss, Gerrit Weimann, Donald F Zoz, Fernando J Martinez, FIBRONEER-ILD Trial Investigators

The New England journal of medicineno. 22 (2025): 2203-2214

Cited0Views0WOSBibtex

Estimating the Effect of Nintedanib on Forced Vital Capacity in Children and Adolescents with Fibrosing Interstitial Lung Disease Using a Bayesian Dynamic Borrowing Approach

Toby M. Maher,Kevin K. Brown,Steven Cunningham,Emily M. DeBoer,Robin Deterding,Elizabeth K. Fiorino,Matthias Griese,Nicolaus Schwerk,David Warburton,Lisa R. Young,Martina Gahlemann,Florian Voss,Christian Stock

Pediatric Pulmonologyno. 4 (2024): 1038-1046

Cited1Views0WOSBibtex

Survival Analysis for AdVerse Events with VarYing Follow-Up Times (savvy)—estimation of Adverse Event Risks

Stegherr Regina,Schmoor Claudia,Beyersmann Jan,Rufibach Kaspar,Jehl Valentine,Brückner Andreas,Eisele Lewin, Künzel Thomas,Kupas Katrin,Langer Frank,Leverkus Friedhelm,Loos Anja,Norenberg Christiane,Voss Florian,Friede Tim

CRAN Contributed Packages（2024）

Cited14Views0WOSBibtex

Plain Language Summary: Clinical Study of BI 1015550 As a Potential Treatment for Idiopathic Pulmonary Fibrosis

Luca Richeldi,Arata Azuma,Vincent Cottin,Christian Hesslinger,Susanne Stowasser,Claudia Valenzuela,Marlies S. Wijsenbeek,Donald F. Zoz,Florian Voss,Toby M. Maher

Journal of Comparative Effectiveness Research（2023）

Cited1Views0WOSBibtex

Design of a Phase III, Double-Blind, Randomised, Placebo-Controlled Trial of BI 1015550 in Patients with Idiopathic Pulmonary Fibrosis (FIBRONEER-IPF)

Toby M. Maher,Shervin Assassi,Arata Azuma,Vincent Cottin,Anna-Maria Hoffmann-Vold,Michael Kreuter,Justin M. Oldham,Luca Richeldi,Claudia Valenzuela,Marlies S. Wijsenbeek,Carl Coeck,Christina Schlecker,Florian Voss,Daniel Wachtlin,Fernando J. Martinez

BMJ OPEN RESPIRATORY RESEARCH（2023）

Cited8Views0WOSBibtex

POS1329 DESIGN OF A PHASE III, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF BI 1015550 IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE

T. Maher,S. Assassi,A. Azuma,V. Cottin,A.M. Hoffmann-Vold,M. Kreuter,J. Oldham,L. Richeldi,C. Valenzuela,M. Wijsenbeek,C. Coeck,F. Voss,D. Wachtlin,F. Martinez

Annals of the Rheumatic Diseases (2023): 1014-1015

Cited0Views0Bibtex

Sécurité D’emploi Et Efficacité De Bl 1015550, Un Inhibiteur Préférentiel De La Phosphodiestérase 4B (pde4bi), Chez Des Patients Atteints De Fibrose Pulmonaire Idiopathique : Essai De Phase II

L. Richeldi,A. Azuma,V. Cottin,C. Hesslinger,S. Stowasser,C. Valenzuela,M. Wijsenbeek,D.F. Zoz,F. Voss,T.M. Maher

Revue des Maladies Respiratoires Actualités（2023）

Cited0Views0Bibtex

DESIGN OF A PHASE III, RANDOMISED, PLACEBOCONTROLLED TRIAL OF BI 1015550 IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE

T. Maher,S. Assassi,A. Azuma,V. Cottin,A. M. Hoffmann-Vold,M. Kreuter,J. Oldham,L. Richeldi,C. Valenzuela,M. Wijsenbeek,C. Coeck,F. Voss,D. Wachtlin,F. Martinez

ANNALS OF THE RHEUMATIC DISEASES (2023): 1014-1015

Cited0Views0Bibtex

Decline in Forced Vital Capacity As a Surrogate for Mortality in Patients with Pulmonary Fibrosis

Toby M. Maher,Susanne Stowasser,Florian Voss,Elisabeth Bendstrup,Michael Kreuter,Fernando J. Martinez,Patricia J. Sime,Christian Stock

RESPIROLOGY（2023）

Cited7Views0WOSBibtex

Safety and Efficacy of BI 1015550, a Preferential Inhibitor of Phosphodiesterase 4b, in Patients with Idiopathic Pulmonary Fibrosis: A Phase 2 Trial

Autoren D. Koschel,L. Richeldi,A. Azuma,V Cottin,C. Hesslinger,S. Stowasser,C. Valenzuela,M. Wijsenbeek, D. Zoz,F. Voss,T. Maher

PNEUMOLOGIE (2023): S51-S52

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn